Application Sponsors
ANDA 064033 | GLAXOSMITHKLINE | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | 0 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM |
FDA Submissions
| ORIG | 1 | AP | 1993-10-31 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1996-05-08 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1998-05-28 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 6 | AP | 2002-07-31 | |
LABELING; Labeling | SUPPL | 7 | AP | 2005-01-28 | |
Submissions Property Types
SUPPL | 2 | Null | 0 |
SUPPL | 3 | Null | 0 |
SUPPL | 6 | Null | 0 |
CDER Filings
GLAXOSMITHKLINE
cder:Array
(
[0] => Array
(
[ApplNo] => 64033
[companyName] => GLAXOSMITHKLINE
[docInserts] => ["",""]
[products] => [{"drugName":"CEFAZOLIN SODIUM","activeIngredients":"CEFAZOLIN SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"CEFAZOLIN SODIUM","submission":"CEFAZOLIN SODIUM","actionType":"EQ 1GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)